Soligenix Revenue and Competitors

Location

$38.7M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Soligenix's estimated annual revenue is currently $7.5M per year.(i)
  • Soligenix's estimated revenue per employee is $326,087
  • Soligenix's total funding is $38.7M.

Employee Data

  • Soligenix has 23 Employees.(i)
  • Soligenix grew their employee count by -8% last year.

Soligenix's People

NameTitleEmail/Phone
1
VP, Project Management & Regulatory AffairsReveal Email/Phone
2
SVP & Chief Scientific OfficerReveal Email/Phone
3
SVP and Chief Financial OfficerReveal Email/Phone
4
Associate Director, Regulatory AffairsReveal Email/Phone
5
SVP and Chief Medical OfficerReveal Email/Phone
6
Finance ManagerReveal Email/Phone
7
Chairman, President & CEOReveal Email/Phone
8
Clinical Research AssociateReveal Email/Phone
9
Senior Quality AssociateReveal Email/Phone
10
Corporate ControllerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.5M55-21%N/AN/A
#2
$0.2M10%N/AN/A
#3
$8.5M55-29%N/AN/A
#4
$108.5M5002%N/AN/A
#5
$0.8M50%N/AN/A
#6
$0.6M40%N/AN/A
#7
$14.7M68-23%$206.4MN/A
#8
$492.2M1503-15%$568MN/A
#9
$1.1M7-42%N/AN/A
#10
$4.5M290%N/AN/A
Add Company

What Is Soligenix?

Soligenix, Inc. (formerly known as DOR BioPharma, Inc.) is a late-stage biopharmaceutical company committed to the development of life-saving therapeutics and vaccines. Soligenix has two areas of focus: 1) a therapeutics platform dedicated to the development of products for life-threatening conditions such as gastrointestinal Graft-versus-Host disease and cancer, and 2) a biodefense platform to develop vaccines for military and civilian applications

keywords:N/A

$38.7M

Total Funding

23

Number of Employees

$7.5M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Soligenix News

2022-04-17 - Is Soligenix (NASDAQ:SNGX) Using Debt Sensibly?

How Healthy Is Soligenix's Balance Sheet? We can see from the most recent balance sheet that Soligenix had liabilities of US$6.29m falling due...

2022-04-13 - Soligenix Receives $1.4M in Non-Dilutive Government Funding

It can be claimed by a range of companies that seek to research or develop an advance in their field. About Soligenix, Inc. Soligenix is a late-...

2022-03-22 - Soligenix Announces Recent Accomplishments And Year-End ...

About Soligenix, Inc. Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.3M23-4%N/A
#2
$3.9M23-8%N/A
#3
N/A235%N/A
#4
$1.6M23-15%$11.4M
#5
N/A23-12%N/A